|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.412 SEK | -2.49% |
|
-4.98% | -68.93% |
| Feb. 23 | Kancera AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 23 | Kancera AB Signs A License Agreement with the University of Newcastle | CI |
Kancera AB (publ) reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported revenue was SEK 0.027 million compared to SEK 1.14 million a year ago. Net loss was SEK 14.01 million compared to SEK 12.95 million a year ago.
Basic loss per share from continuing operations was SEK 0.22 compared to SEK 0.23 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -68.93% | 15.61M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
KANCERA AB 
